New combo therapy shows promise for blood cancer control
NCT ID NCT02180711
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tests a drug called acalabrutinib, alone or with other medicines, in people with a type of blood cancer called B-cell non-Hodgkin lymphoma. The goal is to see if the treatment is safe and helps shrink or control the cancer. About 113 adults with lymphoma that came back or didn't respond to prior treatment took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Edmonton, Alberta, t6G1Z2, Canada
-
Research Site
London, Ontario, N6A 5W9, Canada
-
Research Site
Toronto, Ontario, M5G 2M9, Canada
-
Research Site
Bologna, 40138, Italy
-
Research Site
Milan, 20132, Italy
-
Research Site
Palermo, 90146, Italy
-
Research Site
Tucson, Arizona, 85719, United States
-
Research Site
Downey, California, 90241, United States
-
Research Site
Duarte, California, 91010, United States
-
Research Site
Fountain Valley, California, 92708, United States
-
Research Site
Santa Monica, California, 90404, United States
-
Research Site
Coral Gables FL, Florida, 33146, United States
-
Research Site
Chicago, Illinois, 60611, United States
-
Research Site
Chicago, Illinois, 60612, United States
-
Research Site
Chicago, Illinois, 60637, United States
-
Research Site
Louisville, Kentucky, 40207, United States
-
Research Site
New Orleans, Louisiana, 70112, United States
-
Research Site
Ann Arbor, Michigan, 48109, United States
-
Research Site
Morristown, New Jersey, 07960, United States
-
Research Site
Hawthorne, New York, 10532, United States
-
Research Site
Lake Success, New York, 11042, United States
-
Research Site
New York, New York, 10021, United States
-
Research Site
Syracuse, New York, 13210, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Greenville, South Carolina, 29615, United States
-
Research Site
Dallas, Texas, 75235, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
San Antonio, Texas, 78217, United States
-
Research Site
Temple, Texas, 76508, United States
-
Research Site
Salt Lake City, Utah, 84112, United States
-
Research Site
Spokane, Washington, 99208, United States
-
Research Site
Waukesha, Wisconsin, 53188, United States
Conditions
Explore the condition pages connected to this study.